Veterinary Medicines

Quiflor 100 mg/ml solution for injection for cattle and pigs (sows)

Authorised
  • Marbofloxacin
Download as PDF

Product identification

Medicine name:
Quiflor 100 mg/ml Oplossing voor injectie
Quiflor 100 mg/ml Solution injectable
Quiflor 100 mg/ml Injektionslösung
Quiflor 100 mg/ml solution for injection for cattle and pigs (sows)
Active substance:
  • Marbofloxacin
Target species:
  • Cattle
  • Pig (sow for reproduction)
Route of administration:
  • Intravenous use
  • Subcutaneous use
  • Intramuscular use

Product details

Active substance and strength:
  • Marbofloxacin
    100.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intravenous use
    • Cattle
      • Milk
        36
        hour
      • Meat and offal
        6
        day
  • Subcutaneous use
    • Cattle
      • Milk
        36
        hour
      • Meat and offal
        6
        day
  • Intramuscular use
    • Cattle
      • Milk
        36
        hour
      • Meat and offal
        6
        day
    • Pig (sow for reproduction)
      • Meat and offal
        4
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01MA93
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Belgium
Package description:
  • (ID1) 250 millilitre(s): unspecified outer container with 1 Vial (Glass) with 250 millilitre(s), closed with Stopper (bromobutyl rubber`)
  • (ID2) 100 millilitre(s): unspecified outer container with 1 Vial (Glass) with 100 millilitre(s), closed with Stopper (bromobutyl rubber`)
  • (ID3) 50 millilitre(s): unspecified outer container with 1 Vial (Glass) with 50 millilitre(s), closed with Stopper (bromobutyl rubber`)

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • KRKA tovarna zdravil d.d. Novo mesto
Marketing authorisation date:
Manufacturing sites for batch release:
  • Krka d.d. Novo Mesto
  • Tad Pharma GmbH
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
  • BE-V399655
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0302/001
Concerned member states:
  • Austria
  • Belgium
  • Denmark
  • Greece
  • Italy
  • Lithuania
  • Netherlands
  • Portugal
  • Slovakia
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 25/08/2022
Download
French (PDF)
Published on: 25/08/2022
Download
German (PDF)
Published on: 25/08/2022
Download

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 25/08/2022
Download
French (PDF)
Published on: 25/08/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."